Technical Analysis for ISR - IsoRay, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
 |
0.41 | 2.50% | 0.01 |
ISR closed up 2.5 percent on Friday, January 18, 2019, on 2.03 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.
| ADX | Long-Term | Intermediate-Term | Short-Term |
|---|---|---|---|
| Weak or Absent | Down | Up | Up |
| See historical ISR trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Jan 18 | Pocket Pivot | Bullish Swing Setup | 0.00% |
| Jan 18 | NR7 | Range Contraction | 0.00% |
| Jan 18 | Doji - Bearish? | Reversal | 0.00% |
| Jan 18 | Weak + Overbought | Other | 0.00% |
| Jan 18 | Wide Bands | Range Expansion | 0.00% |
| Jan 18 | Weak, Overbought and Reversal Signs | Reversal | 0.00% |
| Jan 18 | Overbought Stochastic | Strength | 0.00% |
| Jan 18 | Up 3 Days in a Row | Strength | 0.00% |
| Jan 17 | 50 DMA Support | Bullish | 2.50% |
| Jan 17 | MACD Bullish Centerline Cross | Bullish | 2.50% |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 2019-02-14
- Sector: Healthcare
- Industry: Biotechnology & Medical Research
IsoRay, Inc. engages in the development, manufacture, and sale of isotope-based medical products and devices for the treatment of cancer and other malignant diseases primarily in the United States. The company produces Proxcelan Cesium-131 brachytherapy seeds that are used for the treatment of prostate cancer; ocular melanoma; head, neck, and lung tumors; breast cancer; liver cancer; brain cancer; colorectal cancer; gynecological cancer; esophageal cancer; and pancreatic cancers. It also offers GliaSite radiation therapy system, a balloon catheter device, which is used to treat brain cancer. IsoRay, Inc. is based in Richland, Washington.
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength | |||
| Summary: | Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies. | ||
See more ISR news...
Indicators
| Indicator | Value |
|---|---|
| 52 Week High | 1.22 |
| 52 Week Low | 0.269 |
| Average Volume | 176,582 |
| 200-Day Moving Average | 0.4767 |
| 50-Day Moving Average | 0.39 |
| 20-Day Moving Average | 0.3559 |
| 10-Day Moving Average | 0.3873 |
| Average True Range | 0.0361 |
| ADX | 20.93 |
| +DI | 18.0435 |
| -DI | 9.9802 |
| Chandelier Exit (Long, 3 ATRs ) | 0.3117 |
| Chandelier Exit (Short, 3 ATRs ) | 0.3773 |
| Upper Bollinger Band | 0.4322 |
| Lower Bollinger Band | 0.2796 |
| Percent B (%b) | 0.85 |
| BandWidth | 42.877213 |
| MACD Line | 0.0034 |
| MACD Signal Line | -0.0056 |
| MACD Histogram | 0.009 |
| Fundamentals | Value |
|---|---|
| Market Cap | 22.55 Million |
| Num Shares | 55 Million |
| EPS | -0.11 |
| Price-to-Earnings (P/E) Ratio | -3.66 |
| Price-to-Sales | 5.78 |
| Price-to-Book | 2.59 |
| PEG Ratio | 0.00 |
| Dividend | 0.00 |
| Dividend Yield | 0.00% |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.44 | ||||
| Resistance 3 (R3) | 0.44 | 0.43 | 0.44 | ||
| Resistance 2 (R2) | 0.43 | 0.42 | 0.43 | 0.43 | |
| Resistance 1 (R1) | 0.42 | 0.42 | 0.42 | 0.42 | 0.43 |
| Pivot Point | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 |
| Support 1 (S1) | 0.40 | 0.40 | 0.40 | 0.40 | 0.39 |
| Support 2 (S2) | 0.39 | 0.40 | 0.39 | 0.39 | |
| Support 3 (S3) | 0.38 | 0.39 | 0.39 | ||
| Support 4 (S4) | 0.38 |
